← All thesesAXONUnattractiveHigh convictionMonday 9 November 2026עברית

Axon Enterprise

This is the archived full research. Read the story

The company behind the TASER and most American police body cameras, which now sells police the cloud software their evidence, reports and dispatch run on.

Our viewUnattractive High conviction
The scores
The profile · 1-4
Growth4/4 →

Revenue grew 33.5% in 2025 and 28% in Q3 2026, software 43% and recurring revenue 40%, on top of years above 30%.

Business quality4/4 →

One multi-year plan bundles evidence, cameras and TASERs; 126% retention holds although Motorola sells the same cameras and evidence software.

Financial position3/4 →

Net debt near $1.25B with nothing due before 2030, but free cash flow was only $75M in 2025 and is guided near $370M.

Execution record3/4 ↓

Years of 30% growth, but the 2026 outlook was cut on slipped federal drone deals and gross margin fell from 60.1% to 56.7%.

Per share capture2/4 ↑

Stock pay was 22.8% of 2025 revenue and diluted shares rose 35% since 2020; Skydio is partly paid in shares.

Potential3/4 ↑

Records, 911, drones and counter-drone multiply what each officer buys, but the newer lines are early and their market is management's sizing.

Risk profile3/4 →

Buyers are governments with appropriation clauses, antitrust scrutiny follows its share, and Motorola and Flock contest each new line.

Valuation1/4 ↑

About 143.5 times operating profit before depreciation, 204% of a three-stage value near $153 at an 8% return: priced for perfection, beyond the 20% margin.

Evidence quality3/4 →

Revenue, stock pay and the balance sheet are filed; recurring revenue, retention, bookings and the drone market are management's figures.

The bet · 2-3 years
Safe, little upside1.3×

If it works 1.3× · if it fails you keep about 82%.

The Verdict

We rate Axon Unattractive. Its software grew 43% last quarter, and police customers spend more each year and rarely leave, so the business is solid. But stock pay takes about a sixth of revenue, so real profit is thin, margins fell and the outlook was cut on slipped deals. Even with stock pay fading and a steep growth path, the price is about twice our value and above our best case: the 2028 plan is already paid for. As a bet on drones and counter-drone it is defensive: little added if they work, little lost if not.

The long caseIf agencies that bought cameras from Axon add its drones, counter-drone and dispatch software, each officer's plan grows several times over.

How we weighed it

The price against our value

Against it

Price at 204% of our value

The price sits above our value and above the bull case, even on a steep path.

The business

In its favour

Solid

Customers rarely leave and spend more each year.

Growth against what the price assumes

In its favour

Software growth and customer retention both held through the quarter.

What could go wrong

Against it

Government budgets can cancel deals, rivals compete in newer tools and antitrust regulators are watching.

Against competitors

Cuts both ways

Priced close to its main rival on sales.

How its group is behaving

Cuts both ways

It sits in none of our ranked groups; public-safety budgets move it.

The latest news and report

Against it

The last report cut the outlook on slipped deals and margins fell.

The evidence under this - 8 claims
C03facthigh confidence
Q3 2026 revenue was $908.6M, up 28%: Software and Services $437.0M, up 43%, and Connected Devices $471.5M, up 16%, within which TASER fell to $233.0M from $238.0M, Personal Sensors rose to $113.5M and Platform Solutions doubled to $125.0M.
historical · Q3 2026written 2026-11-09
C04management claimmedium confidence
At 30 September 2026 annual recurring revenue was $1,750M, up 40%, net revenue retention 126%, and future contracted bookings $15.8B, up 39%, of which management expects 20% to 25% to be delivered in twelve months.
against this

Future contracted bookings include contracts with termination clauses that are left out of remaining performance obligations, which the 10-Q puts at $10.2B (C05).

current state · 2026-09-30written 2026-11-09
C42inferencemedium confidence
Customers rarely leave: an agency's evidence sits in Axon Evidence, its cameras, TASERs and software come in one multi-year plan, and adding products to that plan is how revenue per customer grows 26% a year.
derivedC04, C21, C22 and C01: retention of 126% with what management calls de minimis attrition, a regulator's 'dominant supplier', and adoption by every large city.
against this

Retention and attrition are management's figures, and the FTC allegation was never tested (C21).

current state · 2026-09-30written 2026-11-09
C09facthigh confidence
Stock-based pay was $634.2M in 2025, 22.8% of revenue, against $382.6M in 2024 and $131.4M in 2023; it was $435.1M in the first nine months of 2026.
historical · 2023 to Q3 2026written 2026-11-09
C18inferencemedium confidence
At $313 company value is about $26.7B: 81.4M shares and net debt of about $1.25B. That is about 7.4 times guided 2026 revenue and about 78 times guided 2026 adjusted EBITDA after stock pay ($926.5M less $585M, about $341.5M). On the 2028 targets with stock pay near $650M, it is about 26 times.
derivedC12, C13, C16, C08, C10 and C19; the $650M of 2028 stock pay is this thesis's assumption A02.
against this

Adjusted EBITDA before stock pay, the figure management and most analysts use, puts the price near 29 times 2026.

current state · 2026-11-06written 2026-11-09
C19management claimmedium confidence
In February 2026 Axon set targets for 2028 of about $6B of revenue and a 28% adjusted EBITDA margin.
against this

The 2026 outlook was cut nine months later (C08), and the 28% margin adds back stock pay (C10).

forwardwritten 2026-11-09
C06management claimmedium confidence
Management says real-time operations, Axon Records, AI, Axon 911 and Dedrone software together reached a revenue run rate of nearly $500M, more than double a year earlier, and that AI recurring revenue passed $100M.
against this

None of these lines is reported in the filings; the run rate is management's figure only.

current state · 2026-09-30written 2026-11-09
C37facthigh confidence
Under the SAFER SKIES Act, a Justice and Homeland Security rule effective 1 July 2026 lets state and local police run counter-drone operations after federal training, with approved systems only.
current state · 2026-07-06written 2026-11-09
01

The company

Police officers carry a TASER and wear a body camera; both come from Axon in most large American departments. The footage uploads to Axon Evidence, a cloud service where prosecutors and courts retrieve it. Around that Axon sells report writing with AI, records, dispatch and 911 software, and now drones and systems that stop drones.

Without it an agency would buy cameras, storage and software from several vendors, often Motorola, and stitch them together itself.

The evidence under this - 6 claims
C01facthigh confidence
Axon sells TASER energy weapons and cartridges, body cameras, in-car and fixed cameras, drones and counter-drone systems, and cloud software for evidence, records, real-time operations, 911 calls and AI tools, mostly to police, corrections and other public safety agencies.
current state · 2025-12-31written 2026-11-09
C42inferencemedium confidence
Customers rarely leave: an agency's evidence sits in Axon Evidence, its cameras, TASERs and software come in one multi-year plan, and adding products to that plan is how revenue per customer grows 26% a year.
derivedC04, C21, C22 and C01: retention of 126% with what management calls de minimis attrition, a regulator's 'dominant supplier', and adoption by every large city.
against this

Retention and attrition are management's figures, and the FTC allegation was never tested (C21).

current state · 2026-09-30written 2026-11-09
C22facthigh confidence
The Bureau of Justice Statistics found that 61.8% of local police departments used body cameras in 2020, against 43.1% in 2016; those departments employed 79.1% of local officers, and every department serving a million people or more used them.
historical · 2016 and 2020written 2026-11-09
C23facthigh confidence
In 2020, 53% of local police departments almost always or always authorised conducted energy devices such as TASERs, and 11.6% used cameras on drones, departments employing 41.1% of local officers.
historical · 2020written 2026-11-09
C14facthigh confidence
On 5 November 2026 Axon agreed to invest about $1.2B in Skydio, roughly 60% cash and 40% Axon stock, taking its stake to 37%, and became Skydio's exclusive public safety distributor in the US and Canada, booking the channel margin as revenue.
current state · 2026-11-05written 2026-11-09
C25facthigh confidence
Motorola Solutions sells body-worn and in-vehicle cameras, evidence software and command centre software to police; video was 16% of its Products and Systems Integration sales and 21% of its Software and Services sales in 2025.
historical · 2025written 2026-11-09

How it makes money

Agencies sign multi-year plans that bundle devices with cloud software, paid each year. Software and services were nearly half of revenue last quarter and grow faster; TASERs, cameras and drones are the rest. Contracted future bookings of $15.8B, more than four years of revenue, keep the money coming.

The evidence under this - 4 claims
C02facthigh confidence
2025 revenue was $2,779.5M, up 33.5%: TASER $913.9M, Personal Sensors (mostly body cameras) $397.0M, Platform Solutions (in-car video, fixed cameras, drones and counter-drone) $265.9M, and Software and Services $1,202.7M, 43.3% of the total.
historical · 2025written 2026-11-09
C03facthigh confidence
Q3 2026 revenue was $908.6M, up 28%: Software and Services $437.0M, up 43%, and Connected Devices $471.5M, up 16%, within which TASER fell to $233.0M from $238.0M, Personal Sensors rose to $113.5M and Platform Solutions doubled to $125.0M.
historical · Q3 2026written 2026-11-09
C04management claimmedium confidence
At 30 September 2026 annual recurring revenue was $1,750M, up 40%, net revenue retention 126%, and future contracted bookings $15.8B, up 39%, of which management expects 20% to 25% to be delivered in twelve months.
against this

Future contracted bookings include contracts with termination clauses that are left out of remaining performance obligations, which the 10-Q puts at $10.2B (C05).

current state · 2026-09-30written 2026-11-09
C05facthigh confidence
Remaining performance obligations were about $10.2B at 30 September 2026.
current state · 2026-09-30written 2026-11-09
Where the money comes from, stream by stream
StreamShare of sales (2025)How it earns it
Software and Services43%Cloud subscriptions for evidence storage, records, real-time operations, AI tools and 911, plus set-up services, mostly billed over multi-year plans.
TASER33%TASER devices, cartridges, extended warranties and training, mostly to police, also to consumers.
Personal Sensors14%Body cameras, accessories and their warranties.
Platform Solutions10%In-car and fixed cameras, interview rooms, drones and counter-drone equipment and virtual reality training hardware.

Who runs it

Rick Smith founded the company as TASER International in 1993 and still runs it; he moved it into cameras and cloud software. Joshua Isner is president and Brittany Bagley runs operations and finance.

Smith owns 3.5%. His pay, and a plan for staff, vest only if the share price clears rising hurdles and revenue or profit goals are met. Insiders bought no shares in the past year and sold steadily, most of it under plans set in advance.

The evidence under this - 4 claims
C48facthigh confidence
Rick Smith founded the company as TASER International in 1993 and runs it; Joshua Isner is president and Brittany Bagley chief operating and financial officer.
current state · 2026-04-16written 2026-11-09
C29facthigh confidence
Founder and chief executive Rick Smith owns 3.5% of the shares; his Performance Award and the Employee XSP vest in seven tranches on price hurdles from $247.40 to $943.75 plus revenue or adjusted EBITDA goals, and tranche 4 needs $483.20 and $3,583M of revenue or $801M of adjusted EBITDA.
current state · 2026-04-16written 2026-11-09
C30facthigh confidence
In 2025 the president's vested XSP shares were worth $87.7M and the finance chief's $39.5M; no tranche of the chief executive's award had vested.
historical · 2025written 2026-11-09
C31facthigh confidence
In the year to October 2026 insiders made no open-market purchases and 254 open-market sales of 221,779 shares, 61.6% of them under Rule 10b5-1 plans; the last were in September near $500.
historical · November 2025 to October 2026written 2026-11-09
02

Why it wins, and who could beat it

Why customers come back

An agency's years of evidence live in Axon's cloud, and its officers' TASERs, cameras and software arrive on one plan that renews together. Leaving means moving the evidence and retraining every officer.

The outside evidence: the Federal Trade Commission called Axon the dominant supplier to large city police in 2020, and existing customers spent 26% more in the past year.

The evidence under this - 4 claims
C42inferencemedium confidence
Customers rarely leave: an agency's evidence sits in Axon Evidence, its cameras, TASERs and software come in one multi-year plan, and adding products to that plan is how revenue per customer grows 26% a year.
derivedC04, C21, C22 and C01: retention of 126% with what management calls de minimis attrition, a regulator's 'dominant supplier', and adoption by every large city.
against this

Retention and attrition are management's figures, and the FTC allegation was never tested (C21).

current state · 2026-09-30written 2026-11-09
C04management claimmedium confidence
At 30 September 2026 annual recurring revenue was $1,750M, up 40%, net revenue retention 126%, and future contracted bookings $15.8B, up 39%, of which management expects 20% to 25% to be delivered in twelve months.
against this

Future contracted bookings include contracts with termination clauses that are left out of remaining performance obligations, which the 10-Q puts at $10.2B (C05).

current state · 2026-09-30written 2026-11-09
C21factmedium confidence
In 2020 the Federal Trade Commission called Axon the dominant supplier of body cameras and evidence systems to large city police departments, and alleged it raised prices substantially after buying its closest rival, VieVu.
against this

The FTC dismissed the case in October 2023 without a ruling on the merits (S11), so the allegation was never tested.

historical · 2020written 2026-11-09
C22facthigh confidence
The Bureau of Justice Statistics found that 61.8% of local police departments used body cameras in 2020, against 43.1% in 2016; those departments employed 79.1% of local officers, and every department serving a million people or more used them.
historical · 2016 and 2020written 2026-11-09

The threat

Motorola Solutions sells body and car cameras, evidence software and command centres to the same agencies, often beside its radios. Flock Safety, a private company, leads license plate readers and real-time centres and is moving into drones, while Axon says nearly 500 agencies have switched readers to it or are in talks.

The evidence under this - 3 claims
C25facthigh confidence
Motorola Solutions sells body-worn and in-vehicle cameras, evidence software and command centre software to police; video was 16% of its Products and Systems Integration sales and 21% of its Software and Services sales in 2025.
historical · 2025written 2026-11-09
C26facthigh confidence
Axon's 10-K names dozens of rivals: Motorola Solutions in cameras, evidence, records, 911 and drone software; Flock Safety in license plate readers, real-time centres and drones; Mark43, Tyler and others in records; and about seventy counter-drone makers including Anduril, DroneShield and Lockheed Martin.
current state · 2025-12-31written 2026-11-09
C41management claimlow confidence
Management says nearly 500 agencies have switched to Axon's license plate readers or are in its pipeline, and that some customers have paused the product while local laws are written.
against this

The Los Angeles police renewal still awaits city council approval months after the old contract expired, an analyst noted on the call.

current state · 2026-11-05written 2026-11-09

The rivals: MSI, MSI, TYL, WRAP, BYRN, LMT, LHX, LDOS, VTSI, and 3 more that are private, in-house or listed abroad.

Who else does this, rival by rival
TickerRivalWhere it competesHow far alongPriced against it
MSIMotorola Solutions, with body cameras, evidence software and CommandCentralPriced against it: YesSoftware and Services: evidence storage, records, real-time operations and AI subscriptionsOn saleYes
Motorola Solutions' body and in-car camerasBody cameras, in-car video and fixed camerasOn sale
PrivateFlock Safety's FlockOS and plate readers, and Mark43 records software, both privatePriced against it: PrivateSoftware and Services: evidence storage, records, real-time operations and AI subscriptionsOn salePrivate
TYLTyler Technologies' public safety records and dispatch softwarePriced against it: One segment onlySoftware and Services: evidence storage, records, real-time operations and AI subscriptionsOn saleOne segment only
WRAP · BYRNWrap Technologies' BolaWrap and Byrna's pepper launchersPriced against it: YesTASER energy weapons, cartridges and trainingOn saleYes
Not listedSmaller camera makers such as Getac, Hikvision and Reveal MediaPriced against it: Not listedBody cameras, in-car video and fixed camerasOn saleNot listed
PrivateFlock Safety's Aerodome and BRINC, private drone-as-first-responder rivalsPriced against it: PrivateNewer lines: AI tools, real-time centres, 911 calls, drones and counter-droneOn salePrivate
LMT · LHX · LDOSDefence makers selling counter-drone systems: Lockheed Martin, L3Harris, Leidos and the private AndurilPriced against it: Not checkedNewer lines: AI tools, real-time centres, 911 calls, drones and counter-droneOn saleNot checked
VTSIVirTraPriced against it: One segment only-On saleOne segment only
03

How big it could get

How big this could get

There are about 788,000 sworn officers in 17,541 American state and local agencies. In 2020, 62% of local departments used body cameras and 12% used drones, so the newer tools have room to spread.

Nobody publishes what an agency spends per officer on this kit, so the market cannot be put in dollars from outside the company.

The evidence under this - 4 claims
C24facthigh confidence
In 2018 there were 17,541 state and local law enforcement agencies in the US, employing 788,000 full-time sworn officers.
historical · 2018written 2026-11-09
C22facthigh confidence
The Bureau of Justice Statistics found that 61.8% of local police departments used body cameras in 2020, against 43.1% in 2016; those departments employed 79.1% of local officers, and every department serving a million people or more used them.
historical · 2016 and 2020written 2026-11-09
C23facthigh confidence
In 2020, 53% of local police departments almost always or always authorised conducted energy devices such as TASERs, and 11.6% used cameras on drones, departments employing 41.1% of local officers.
historical · 2020written 2026-11-09
C04management claimmedium confidence
At 30 September 2026 annual recurring revenue was $1,750M, up 40%, net revenue retention 126%, and future contracted bookings $15.8B, up 39%, of which management expects 20% to 25% to be delivered in twelve months.
against this

Future contracted bookings include contracts with termination clauses that are left out of remaining performance obligations, which the 10-Q puts at $10.2B (C05).

current state · 2026-09-30written 2026-11-09

Who has signed

Contracts already signed and not yet delivered come to about $10.2B, and the company counts $15.8B of future bookings. Two deals last quarter were worth $258M and $115M. Government contracts can be cancelled if funding is not voted, and three federal counter-drone deals worth about $200M of bookings slipped.

The evidence under this - 4 claims
C05facthigh confidence
Remaining performance obligations were about $10.2B at 30 September 2026.
current state · 2026-09-30written 2026-11-09
C04management claimmedium confidence
At 30 September 2026 annual recurring revenue was $1,750M, up 40%, net revenue retention 126%, and future contracted bookings $15.8B, up 39%, of which management expects 20% to 25% to be delivered in twelve months.
against this

Future contracted bookings include contracts with termination clauses that are left out of remaining performance obligations, which the 10-Q puts at $10.2B (C05).

current state · 2026-09-30written 2026-11-09
C36management claimmedium confidence
Axon reports Q3 2026 bookings including a $258M AI Era Plan and camera expansion and a $115M camera, AI and Fusus deal with two state corrections departments, and an $18M Dedrone deployment with a federal agency; five-year bookings rose 25% in nine months.
against this

Bookings are unaudited and include contracts with cancellation clauses.

current state · 2026-09-30written 2026-11-09
C32management claimmedium confidence
Management says the three federal Dedrone deployments, about $130M of revenue and $200M of bookings, slipped on procurement, the election, export permits and site work, and that it will guide such deals only once confident they ship.
against this

A deployment that slips twice is a deal at risk, and nothing filed says the orders are signed.

forwardwritten 2026-11-09
Where the growth is coming from, business by business

Where the growth is coming from

BusinessShare of revenueGrowth: last quarterLast half-yearLast yearShare in 3 years at its latest-quarter rate
Software and Services: evidence storage, records, real-time operations and AI subscriptions48%+43.2%--59%
Body cameras, in-car video and fixed cameras26%+42.4%--31%
TASER energy weapons, cartridges and training26%-2.1%--10%
Whole company100%+27.8%--100%

On the filed split through 2026-09-30, if each business keeps its latest quarter's growth, the company grows about 31% next year and 37% in year 3, against 33.6% over the last twelve months. Software and Services: evidence storage, records, real-time operations and AI subscriptions carries the case: it grows 43% against 20% for the rest, and would be 59% of revenue by then. A scenario, not a forecast: no business holds its rate.

How we read it: The score believes the software line: it is nearly half of revenue, grows twice as fast as devices and carries the recurring revenue, so the blend understates where growth is heading.

04

The results

The numbers

Is it growing?Fast

Sales grew 34% over the twelve months to Sep 2026, about the same pace as the 33% in the year to Dec 2025.

Dec 2021: $866MDec 2022: $1.19BDec 2023: $1.56BDec 2024: $2.08BDec 2025: $2.78B12 mo to Sep 2026: $3.42B$866M$3.42B
Is it profitable?Thin

Operating margin is 2.0%, down from 10% in the year to Dec 2023.

Dec 2021: −19%Dec 2022: 7.8%Dec 2023: 10%Dec 2024: 2.8%Dec 2025: −2.2%12 mo to Sep 2026: 2.0%−19%2.0%
Does growth pay off?Costly

Running costs take 57¢ of each sales dollar, down from 82¢ in the year to Dec 2021.

Dec 2021: 82¢Dec 2022: 53¢Dec 2023: 51¢Dec 2024: 57¢Dec 2025: 62¢12 mo to Sep 2026: 57¢82¢57¢
Does it earn good returns?Low

Each dollar put into the business earns 1.2% a year after tax, about where it was (4.6%) in the year to Dec 2022.

Dec 2022: 4.6%Dec 2023: 7.4%Dec 2024: 2.2%Dec 2025: −1.5%12 mo to Sep 2026: 1.2%4.6%1.2%
Is it making cash?Thin

It turned 2.4% of sales into free cash, $80.9M over the last twelve months.

Dec 2021: $74.6MDec 2022: $180MDec 2023: $130MDec 2024: $330MDec 2025: $75.1M12 mo to Sep 2026: $80.9M$74.6M$80.9M
Is the balance sheet safe?Strained

It owes $1.21B more than the cash it holds, about 5.4 years of the cash its operations bring in.

Dec 2022: $261MDec 2023: $565MDec 2024: $108MDec 2025: −$104M12 mo to Sep 2026: −$1.21B$261M−$1.21B
Are shares being diluted?Diluting

The share count rose 26% in 4.8 years, and pay in shares costs 19% of sales.

Dec 2021: 66.2MDec 2022: 72.5MDec 2023: 75.5MDec 2024: 78.6MDec 2025: 82.4M12 mo to Sep 2026: 83.7M66.2M83.7M
All the numbers

Filed figures from the company's 10-K and 10-Q, read 2026-11-10. Fiscal years end in December.

Dec 2021Dec 2022Dec 2023Dec 2024Dec 202512 mo to Sep 2026
Size and growth
Sales$866M$1.19B$1.56B$2.08B$2.78B$3.42B
Sales growth+27%+37%+31%+33%+33%+34%
Profit
Gross margin63%61%61%60%60%59%
Operating margin−19%7.8%10%2.8%−2.2%2.0%
Net margin−6.5%12%11%18%4.5%7.6%
What growth costs, per sales dollar
Research and development22%20%19%21%25%23%
Selling, general and admin59%34%32%36%37%34%
Pay in shares35%8.9%8.4%18%23%19%
Capital spending5.8%4.7%3.8%3.8%4.9%4.2%
Cash
Cash from operations$124M$235M$189M$408M$211M$225M
Free cash flow$74.6M$180M$130M$330M$75.1M$80.9M
Balance sheet
Cash and short-term investments$371M$935M$1.24B$788M$1.71B$1.66B
Debt-$674M$677M$680M$1.81B$2.87B
Net cash-$261M$565M$108M−$104M−$1.21B
Returns and shares
Return on capital-4.6%7.4%2.2%−1.5%1.2%
Shares (diluted)66.2M72.5M75.5M78.6M82.4M83.7M

What growth costs

Growth has been getting more expensive. Research and selling costs have risen faster than revenue, mostly because of stock pay, so reported profit fell to a loss in 2025 before recovering slightly this year. Management expects stock pay to fall as a share of revenue.

The evidence under this - 3 claims
C43facthigh confidence
In 2025 research and development was $684.3M, 24.6% of revenue, and selling and admin $1,035.9M, 37.3%, against 19.5% and 31.7% in 2023; capital spending was $136.3M, 4.9% of revenue.
historical · 2023 and 2025written 2026-11-09
C09facthigh confidence
Stock-based pay was $634.2M in 2025, 22.8% of revenue, against $382.6M in 2024 and $131.4M in 2023; it was $435.1M in the first nine months of 2026.
historical · 2023 to Q3 2026written 2026-11-09
C11facthigh confidence
GAAP operating income was a loss of $62.1M in 2025 and a profit of $118.1M in the first nine months of 2026, 4.5% of revenue, while adjusted EBITDA in those nine months was $679.3M.
historical · 2025 to Q3 2026written 2026-11-09

The last report (5 Nov)

Quarter ended September 2026, filed figures.

28%
Sales growth
against the same quarter a year earlier
0.5%
Growth from the quarter before
against 12.0% the quarter before that
5¢
Operating profit
per dollar of sales

In the quarter to September 2026 revenue rose 28% to $908.6M. Software and services rose 43% and newer software lines reached about $500M a year at their current pace. Devices grew more slowly, and gross margin fell from 60.1% to 56.7% on counter-drone hardware, tariffs and the cost of running AI.

Three federal counter-drone deployments slipped past year end, so Axon cut its 2026 revenue outlook to about 30% growth. Management says it will now guide such deals only once confident they ship.

What it did to the thesisIt supported the software engine: growth and retention held. It weakened the profit side: margins fell and the outlook was cut on deals that slipped, so the plan's timing is less certain and our view holds.

The quarter in detail

Sales growth from the previous quarter, filed figures. The company has restated its own history, so a quarter either side of the restatement may describe a different business; n/c marks one that does not compare.

Earnings per share $1.72 against $1.89 expected; $0.68 as filed, the gap being what the company adds back.

The evidence under this - 6 claims
C03facthigh confidence
Q3 2026 revenue was $908.6M, up 28%: Software and Services $437.0M, up 43%, and Connected Devices $471.5M, up 16%, within which TASER fell to $233.0M from $238.0M, Personal Sensors rose to $113.5M and Platform Solutions doubled to $125.0M.
historical · Q3 2026written 2026-11-09
C07facthigh confidence
Q3 2026 gross margin was 56.7% against 60.1% a year earlier, and Connected Devices gross margin 43.0% against 49.9%, which the company puts down to more counter-drone equipment and higher memory costs.
historical · Q3 2026written 2026-11-09
C08management claimhigh confidence
On 5 November 2026 Axon cut its 2026 outlook to revenue of $3.61B to $3.63B, about 30% growth, from 32% to 34%, leaving out about $130M from three delayed federal Dedrone deployments; adjusted EBITDA of $924M to $929M and free cash flow of $350M to $400M, from $450M.
against this

Management says the deals are delayed, not lost, and will be counted as upside if they ship by year end (C32).

forwardwritten 2026-11-09
C32management claimmedium confidence
Management says the three federal Dedrone deployments, about $130M of revenue and $200M of bookings, slipped on procurement, the election, export permits and site work, and that it will guide such deals only once confident they ship.
against this

A deployment that slips twice is a deal at risk, and nothing filed says the orders are signed.

forwardwritten 2026-11-09
C46facthigh confidence
Software and Services gross margin was 71.4% in Q3 2026 against 73.8% a year earlier; the company says software alone still earns over 80%.
historical · Q3 2026written 2026-11-09
C06management claimmedium confidence
Management says real-time operations, Axon Records, AI, Axon 911 and Dedrone software together reached a revenue run rate of nearly $500M, more than double a year earlier, and that AI recurring revenue passed $100M.
against this

None of these lines is reported in the filings; the run rate is management's figure only.

current state · 2026-09-30written 2026-11-09
What management did with the money

Insiders in 2026Q3: 16 purchases and 128 sales, from their Form 4 filings.

05

The price, and where we disagree

In short. Priced for perfection. The price is about 204% of what we think the business is worth, at an 8% yearly return.

Share price
$313.00
close,
Company value for each $1 of sales
7.6
rivals' middle 9.4
Company value for each $1 of cash profit
59.2
its 6-year normal 105.2

The shares halved in a year while revenue per share rose 25%, and fell 26% in two days after the third-quarter report, when the counter-drone deals slipped. After similar drops in 2025 and August 2026 the price recovered within weeks.

The next test is the fourth-quarter report, expected on 23 February 2027, with the 2027 outlook: how fast revenue grows and how much stock pay falls.

The evidence under this - 5 claims
C16facthigh confidence
The shares closed at $313 on 6 November 2026, down 51% in 252 sessions while revenue per share rose 25%, so the price paid for each dollar of trailing sales per share fell from 19.6 to 7.7.
current state · 2026-11-06written 2026-11-09
C17facthigh confidence
The shares fell from $424.18 before the Q3 print to $382.56 on 5 November and $313 on 6 November, 26% in two sessions.
historical · 4 to 6 November 2026written 2026-11-09
C45facthigh confidence
The shares fell from $706.13 to $587.14 in two sessions after the Q3 2025 print, and from $609.49 to $522.46 after Q2 2026, before rising to $645.72 in August 2026.
historical · November 2025 to August 2026written 2026-11-09
C08management claimhigh confidence
On 5 November 2026 Axon cut its 2026 outlook to revenue of $3.61B to $3.63B, about 30% growth, from 32% to 34%, leaving out about $130M from three delayed federal Dedrone deployments; adjusted EBITDA of $924M to $929M and free cash flow of $350M to $400M, from $450M.
against this

Management says the deals are delayed, not lost, and will be counted as upside if they ship by year end (C32).

forwardwritten 2026-11-09
C32management claimmedium confidence
Management says the three federal Dedrone deployments, about $130M of revenue and $200M of bookings, slipped on procurement, the election, export permits and site work, and that it will guide such deals only once confident they ship.
against this

A deployment that slips twice is a deal at risk, and nothing filed says the orders are signed.

forwardwritten 2026-11-09
The betSafe, little upside
If it works
1.3×
from today's value, at the stated multiple
If it fails
keep 82%
of today's market value: the rest of the company, less its debt
How we value it
Method
Cash the business will produce, in three stages
Required return
8%
Long-run growth
4%
Moat
A strong moat
BearBaseBull
Sales growth, years 1 to 315.9%, 14.2%31.8%, 28.5%39.8%, 35.6%
Normal operating margin10.9%13.7%15%
Return on new capital after year ten8%15%15%
Value a share$45.09$153$216
Price
$313
Priced on
6 Nov
Price as a share of the base value
204%
Yearly return the price offers on the base case
6.2%
Risk check: valued at 10%, the rate for a cyclical or indebted business
$87.58

Where each figure comes from

FigureSourceWhere exactly
Sales, the last twelve monthsFiled reportQuarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the four quarters to that date.
Operating margin todayFiled reportQuarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the four quarters to that date.
Tax rateOur method's ruleThe normal rate where no rate is filed to read: 25% for a US company, 21% elsewhere.
Sales per dollar of new capitalFiled reportAnnual report (10-K) for the period to 31 Dec 2025, filed 25 Feb 2026: the year's sales over its operating capital.
SharesFiled reportQuarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the diluted share count.
Cash and investmentsFiled reportQuarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the balance sheet on that date.
DebtFiled reportQuarterly report (10-Q) for the period to 30 Sep 2026, filed 6 Nov 2026; the balance sheet on that date.
Sales growth, years 1 to 3Analysts' forecastsFMP's consensus for the years to 31 Dec 2026 and 31 Dec 2027, as it stood when the value was struck on 10 Nov 2026: the average of 13 to 15 analysts' revenue estimates, 31.8%, 28.5%. FMP publishes how many analysts, not who they are.
Normal operating marginAnalysts' forecastsFMP's consensus operating margin for the year to 31 Dec 2028, the average of 14 analysts' estimates, 23.7%, less stock pay of 6% of sales and less the 3% the analysts add back on their adjusted basis: 14.7%, which the base case takes as 13.7%. FMP publishes how many analysts, not who they are.
Return on new capital after year tenOur method's ruleSet by our reading of the moat: the 8% rate with none, 12% with an average one, 15% with a strong one; the bear case earns the rate.
The bear and bull casesOur method's ruleOur method's spread: the bear case takes half the growth and a fifth off the margin, the bull a quarter more growth and a tenth more margin.
PriceMarket priceFMP's closing price on 6 Nov 2026.

What each case rests on

Bear caseGrowth runs at half the analysts' path, 16% and 14%, the margin settles a fifth lower at 10.9%, and new capital earns only the 8% rate: the downturn test.

Base caseRevenue grows 32% and 28% over three years, the analysts' path (C52), then fades toward 4%, closing 30% of the gap each year; the margin moves to 13.7%, the analysts' year-three figure after stock pay and on the filed basis (3.0% less), with stock pay, today 18.8% of sales, at a mature 6%.

Bull caseGrowth runs a quarter above the analysts' path, 40% and 36%, the margin reaches 15.0%, and new capital earns 15%.

What moves the base value

LowerHigher
Growth in years 1 to 3, a quarter lower or higher$120$194
The normal margin, 15% lower or higher$125$182
Capital per dollar of growth, a quarter more or less$146$158
Return on new capital after year ten, at the rate or one step up$101$153
The rate, a point higher or lower$114$220
Long-run growth a point lower$129-

Value a share as growth and margin change

Normal margin ↓ · growth →50%75%100%125%150%
11%$69.63$90.24$116$146$184
12.3%$81.21$105$134$170$213
13.7%$92.79$120$153$194$243
15.1%$104$135$172$218$273
16.4%$116$150$191$241$302

Growth is shown as a share of the base case's. Green: the price is at or under 80% of that value. Red: at or over 120%.

How we read the multiple

Management's profit measure leaves out stock pay. We count it as the cost it is.

  1. The whole company, debt included and cash taken off, is worth about $26.7B.
  2. This year's guided profit, less about $585M of stock pay, is about $340M: about 78 times.
  3. The 2028 targets, $6B of revenue at a 28% margin, less about $650M of stock pay, give about $1.03B.
  4. Today's value is about 26 times that, so the plan landing on time is what the price assumes.

Against its own history. Well below its own six-year normal on company value per dollar of cash profit, so the market has stopped paying the old premium for growth.

The evidence under this - 4 claims
C18inferencemedium confidence
At $313 company value is about $26.7B: 81.4M shares and net debt of about $1.25B. That is about 7.4 times guided 2026 revenue and about 78 times guided 2026 adjusted EBITDA after stock pay ($926.5M less $585M, about $341.5M). On the 2028 targets with stock pay near $650M, it is about 26 times.
derivedC12, C13, C16, C08, C10 and C19; the $650M of 2028 stock pay is this thesis's assumption A02.
against this

Adjusted EBITDA before stock pay, the figure management and most analysts use, puts the price near 29 times 2026.

current state · 2026-11-06written 2026-11-09
C10management claimmedium confidence
Axon guides 2026 stock-based pay at $570M to $600M, about 16% of guided revenue, including about $240M for the Employee XSP and the CEO Performance Award.
against this

Stock pay that hangs on price hurdles can fall if the price stays below them, or rise when new tranches are granted (C29).

forwardwritten 2026-11-09
C19management claimmedium confidence
In February 2026 Axon set targets for 2028 of about $6B of revenue and a 28% adjusted EBITDA margin.
against this

The 2026 outlook was cut nine months later (C08), and the 28% margin adds back stock pay (C10).

forwardwritten 2026-11-09
C40facthigh confidence
The vendor's six-year median company value to sales is 12.0 against 7.9 today, and its median price to sales 12.2 against 7.4.
current state · 2026-11-09written 2026-11-09
Priced against its rivals

The competitors its own annual report names, each confirmed against the rival's filing. Measured on company value for each $1 of sales, cheapest first:

TickerCompanycompany value for each $1 of sales
MSIMotorola Solutions7.5×
AXONAxon Enterprise7.6×
WRAPWrap Technologies11.3×

The middle of the other 2 is 9.4. Axon Enterprise, Inc. is 2nd cheapest of 3.

Rivals' figures come from a data provider, so read the spread of the group rather than any single pair.

Just above Motorola and below the much smaller Wrap, so on sales Axon is priced close to its main rival; the group is too small to say more.

The bet: what it pays if it works

This bet is on Axon's newer lines: AI tools, real-time centres, 911, drones and systems that stop drones. Local police were allowed to run counter-drone operations only from July 2026, and the federal deals have slipped.

Valued alone, TASERs, cameras and evidence software do not cover today's price, so part of the price already rests on the newer lines. If they treble, the shares gain only modestly; if they never earn, little is lost, which makes it a defensive and expensive bet.

Newer lines: AI tools, real-time centres, 911 calls, drones and counter-drone revenue in two to three yearsUS agencies equipped with drones neededAt the stated multiple
$1.50B (the big win)about 4.5K at 30% kept1.3×
$2.50Babout 9.0K at 30% kept1.6×

To pay 2× (a Fair bet) it would need about $3.80B of Newer lines: AI tools, real-time centres, 911 calls, drones and counter-drone revenue (about 14.8K US agencies equipped with drones at 30% kept); to pay 5× (a Cheap bet), about $13.48B of Newer lines: AI tools, real-time centres, 911 calls, drones and counter-drone revenue (about 58.4K US agencies equipped with drones at 30% kept), at the same multiple.

Each row is Newer lines: AI tools, real-time centres, 911 calls, drones and counter-drone alone, plus the rest of the company (TASERs, cameras and evidence software) counted at about $21.25B.

The steps it has to take

  • Done Local police allowed to run counter-drone operations
  • Slipped Slipped federal counter-drone deployments ship due 2027-06
  • In progress Skydio investment closes due 2027-03
  • Not started Newer-line run rate reported above one billion dollars due 2028-03
The detail behind the label
Rating
Expensive
the big win's payoff against the 2× and 5× lines
Cheap bet at about
≈ $77.07
75% below the price (close, )
The option
2.6×
what Newer lines: AI tools, real-time centres, 911 calls, drones and counter-drone is worth if it works, against what the price pays for it
The evidence under this - 6 claims
C06management claimmedium confidence
Management says real-time operations, Axon Records, AI, Axon 911 and Dedrone software together reached a revenue run rate of nearly $500M, more than double a year earlier, and that AI recurring revenue passed $100M.
against this

None of these lines is reported in the filings; the run rate is management's figure only.

current state · 2026-09-30written 2026-11-09
C37facthigh confidence
Under the SAFER SKIES Act, a Justice and Homeland Security rule effective 1 July 2026 lets state and local police run counter-drone operations after federal training, with approved systems only.
current state · 2026-07-06written 2026-11-09
C32management claimmedium confidence
Management says the three federal Dedrone deployments, about $130M of revenue and $200M of bookings, slipped on procurement, the election, export permits and site work, and that it will guide such deals only once confident they ship.
against this

A deployment that slips twice is a deal at risk, and nothing filed says the orders are signed.

forwardwritten 2026-11-09
C15management claimlow confidence
Axon puts the US and Canadian market for drones as first responders at about $13B, and says Skydio serves over 1,500 public safety customers and expects about $1B of bookings this fiscal year.
against this

The market size is Axon's own estimate and is not built from units anywhere in the filing.

forwardwritten 2026-11-09
C18inferencemedium confidence
At $313 company value is about $26.7B: 81.4M shares and net debt of about $1.25B. That is about 7.4 times guided 2026 revenue and about 78 times guided 2026 adjusted EBITDA after stock pay ($926.5M less $585M, about $341.5M). On the 2028 targets with stock pay near $650M, it is about 26 times.
derivedC12, C13, C16, C08, C10 and C19; the $650M of 2028 stock pay is this thesis's assumption A02.
against this

Adjusted EBITDA before stock pay, the figure management and most analysts use, puts the price near 29 times 2026.

current state · 2026-11-06written 2026-11-09
C19management claimmedium confidence
In February 2026 Axon set targets for 2028 of about $6B of revenue and a 28% adjusted EBITDA margin.
against this

The 2026 outlook was cut nine months later (C08), and the 28% margin adds back stock pay (C10).

forwardwritten 2026-11-09

Where we disagree with the market

The market believes

A 30% grower held back by timing, still mostly buy-rated, with targets far above the price.

We believe

The software engine is real, but stock pay and newer hardware keep profit per share well behind revenue.

Analysts value Axon on management's profit, which adds stock pay back. Counted as a cost, the plan needs stock pay to fall to about a ninth of revenue by 2028, and the price already assumes it.

The evidence against us: if the 2027 outlook shows stock pay falling fast while growth holds near 25%, today's price would look cheap.

What analysts say, and the evidence
Analysts positive
86%
of 22, 1 Nov
Four months earlier
82%
of 22, 1 Jul
The evidence under this - 6 claims
C20facthigh confidence
Against the company's 2026 outlook of $3.61B to $3.63B, analysts' averages are $3.71B of revenue for 2026, $4.81B for 2027 and $6.16B for 2028; 19 of 22 rate the shares a buy, and their average target fell 13% from a year earlier.
current state · 2026-11-09written 2026-11-09
C16facthigh confidence
The shares closed at $313 on 6 November 2026, down 51% in 252 sessions while revenue per share rose 25%, so the price paid for each dollar of trailing sales per share fell from 19.6 to 7.7.
current state · 2026-11-06written 2026-11-09
C18inferencemedium confidence
At $313 company value is about $26.7B: 81.4M shares and net debt of about $1.25B. That is about 7.4 times guided 2026 revenue and about 78 times guided 2026 adjusted EBITDA after stock pay ($926.5M less $585M, about $341.5M). On the 2028 targets with stock pay near $650M, it is about 26 times.
derivedC12, C13, C16, C08, C10 and C19; the $650M of 2028 stock pay is this thesis's assumption A02.
against this

Adjusted EBITDA before stock pay, the figure management and most analysts use, puts the price near 29 times 2026.

current state · 2026-11-06written 2026-11-09
C19management claimmedium confidence
In February 2026 Axon set targets for 2028 of about $6B of revenue and a 28% adjusted EBITDA margin.
against this

The 2026 outlook was cut nine months later (C08), and the 28% margin adds back stock pay (C10).

forwardwritten 2026-11-09
C10management claimmedium confidence
Axon guides 2026 stock-based pay at $570M to $600M, about 16% of guided revenue, including about $240M for the Employee XSP and the CEO Performance Award.
against this

Stock pay that hangs on price hurdles can fall if the price stays below them, or rise when new tranches are granted (C29).

forwardwritten 2026-11-09
C09facthigh confidence
Stock-based pay was $634.2M in 2025, 22.8% of revenue, against $382.6M in 2024 and $131.4M in 2023; it was $435.1M in the first nine months of 2026.
historical · 2023 to Q3 2026written 2026-11-09
06

What could go wrong, and how we would know

The risks

  • Government budgets. Agencies can cancel when funding is not voted, and federal counter-drone deals already slipped once.
  • Rivals in newer tools. Motorola and Flock compete in every new line, from plate readers to real-time centres and drones.
  • Antitrust. Regulators have called Axon dominant before; another challenge could limit acquisitions or bundling.
  • Stock pay stays high. If stock pay does not fall as planned, each share keeps getting a smaller slice of the profit.
  • Hardware squeezes margins. Drones, counter-drone and new cameras earn less than software and carry tariffs and memory costs.
The evidence under this - 8 claims
C28facthigh confidence
The 10-K lists as risks non-appropriation and cancellation clauses in government contracts, agencies' funding, and the classification of TASER devices as firearms by the Bureau of Alcohol, Tobacco, Firearms and Explosives.
current state · 2025-12-31written 2026-11-09
C32management claimmedium confidence
Management says the three federal Dedrone deployments, about $130M of revenue and $200M of bookings, slipped on procurement, the election, export permits and site work, and that it will guide such deals only once confident they ship.
against this

A deployment that slips twice is a deal at risk, and nothing filed says the orders are signed.

forwardwritten 2026-11-09
C25facthigh confidence
Motorola Solutions sells body-worn and in-vehicle cameras, evidence software and command centre software to police; video was 16% of its Products and Systems Integration sales and 21% of its Software and Services sales in 2025.
historical · 2025written 2026-11-09
C26facthigh confidence
Axon's 10-K names dozens of rivals: Motorola Solutions in cameras, evidence, records, 911 and drone software; Flock Safety in license plate readers, real-time centres and drones; Mark43, Tyler and others in records; and about seventy counter-drone makers including Anduril, DroneShield and Lockheed Martin.
current state · 2025-12-31written 2026-11-09
C21factmedium confidence
In 2020 the Federal Trade Commission called Axon the dominant supplier of body cameras and evidence systems to large city police departments, and alleged it raised prices substantially after buying its closest rival, VieVu.
against this

The FTC dismissed the case in October 2023 without a ruling on the merits (S11), so the allegation was never tested.

historical · 2020written 2026-11-09
C09facthigh confidence
Stock-based pay was $634.2M in 2025, 22.8% of revenue, against $382.6M in 2024 and $131.4M in 2023; it was $435.1M in the first nine months of 2026.
historical · 2023 to Q3 2026written 2026-11-09
C14facthigh confidence
On 5 November 2026 Axon agreed to invest about $1.2B in Skydio, roughly 60% cash and 40% Axon stock, taking its stake to 37%, and became Skydio's exclusive public safety distributor in the US and Canada, booking the channel margin as revenue.
current state · 2026-11-05written 2026-11-09
C07facthigh confidence
Q3 2026 gross margin was 56.7% against 60.1% a year earlier, and Connected Devices gross margin 43.0% against 49.9%, which the company puts down to more counter-drone equipment and higher memory costs.
historical · Q3 2026written 2026-11-09
What we still do not know
  • How much the newer lines, drones and counter-drone especially, earn on their own; Axon reports only one combined figure for them.
  • How fast stock pay falls as a share of revenue after 2026.
  • What the Skydio stake earns Axon, and whether it leads to full ownership.
The evidence under this - 4 claims
C06management claimmedium confidence
Management says real-time operations, Axon Records, AI, Axon 911 and Dedrone software together reached a revenue run rate of nearly $500M, more than double a year earlier, and that AI recurring revenue passed $100M.
against this

None of these lines is reported in the filings; the run rate is management's figure only.

current state · 2026-09-30written 2026-11-09
C15management claimlow confidence
Axon puts the US and Canadian market for drones as first responders at about $13B, and says Skydio serves over 1,500 public safety customers and expects about $1B of bookings this fiscal year.
against this

The market size is Axon's own estimate and is not built from units anywhere in the filing.

forwardwritten 2026-11-09
C10management claimmedium confidence
Axon guides 2026 stock-based pay at $570M to $600M, about 16% of guided revenue, including about $240M for the Employee XSP and the CEO Performance Award.
against this

Stock pay that hangs on price hurdles can fall if the price stays below them, or rise when new tranches are granted (C29).

forwardwritten 2026-11-09
C14facthigh confidence
On 5 November 2026 Axon agreed to invest about $1.2B in Skydio, roughly 60% cash and 40% Axon stock, taking its stake to 37%, and became Skydio's exclusive public safety distributor in the US and Canada, booking the channel margin as revenue.
current state · 2026-11-05written 2026-11-09

What would change our view

  1. Unattractive→NeutralThe price falls back within 20% of fair value

    It needs:

    • ○The share price falls to about $184, back within 20% of what we think the business is worth.about ≈$189.76 today, 39% below the last close
  2. Unattractive→AttractiveThe price falls 20% under fair value

    It needs:

    • ○The share price falls to about $123, 80% of what we think the business is worth.about ≈$131.09 today, 58% below the last close
  3. Unattractive→AttractiveStock pay falls while growth holds

    It needs all of:

    • ○The 2027 outlook puts stock pay below 13% of revenue.checked at the next results, due by 23 Feb
    • ○The 2027 outlook keeps revenue growth at 25% or more.checked at the next results, due by 23 Feb
We would also be wrong if
  • A top-ten American city moves its body cameras and evidence to another vendor.

What is coming

  • 23 February 2027 Q4 2026 results and 2027 outlook: Whether 2027 is guided near 25% growth, whether stock pay falls as a share of revenue, and whether the federal Dedrone deals shipped.
Every dated event ahead
  • 23 February 2027 Q4 2026 results and 2027 outlook: Whether 2027 is guided near 25% growth, whether stock pay falls as a share of revenue, and whether the federal Dedrone deals shipped.
  • 31 March 2027 Skydio investment closes: How many shares are issued and when drone sales start flowing through Axon.
  • 30 June 2027 Axon Body 5 ships: Whether the new camera starts an upgrade cycle after the Q1 pause management expects.
Since we wrote this
Written
9 Nov
Price the thesis read
$313.00
6 Nov
  • 11 NovThesis reviewUnattractive, high conviction: the view holds even in our best caseConviction re-graded on the new anchors: how robust the view is, not whether anything is still open.
  • 9 NovThesis writtenNeutral, medium convictionThe police platform grows fast and customers stay, but after stock pay the halved price still pays for the 2028 plan.
  • 9 NovThesis reviewUnattractive: priced at 185% of a value near $169Re-valued in three stages at an 8% return, the method now drawn on every thesis: the price sits beyond the 20% margin of safety.

Sources 17

Where this came from

Sources - 17

Every claim above cites one of these, or states the reasoning that derived it. The quote is frozen at the date it was read: a link can rot, and an agent fetch returns a reading of a page rather than the page. Backs counts the whole claim ledger, so it can name a claim this page does not surface.

  1. S01primarycompany filing2026-02-25
    business, segments, sales by product line, competition, customers, suppliers, risk factors and the five-year statements
    backsC01C02C09C11C13C16C26C27C28C39C43C44C48
  2. S02primarycompany filing2026-02-24
    2025 results, annual recurring revenue, bookings, the 2026 outlook and the 2028 targets
    backsC19C49
  3. S03primarycompany filing2026-11-05
    Q3 2026 results by product line and segment, margins, stock pay, cash and notes, recurring metrics, large bookings and the cut 2026 outlook
    backsC03C04C06C07C08C09C10C11C12C20C33C34C35C36C39C46C47C50
  4. S04primarycompany filing2026-11-05
    the Skydio investment, the stake, the exclusive distribution rights and Skydio's bookings and customers
    backsC14C15
  5. S05primarycompany filing2026-11-06
    remaining performance obligations, the notes and their conversion terms, the diluted share count and the shares outstanding
    backsC05C12C13C16C38C49
  6. S06primarytranscript2026-11-05
    Third quarter 2026 earnings call transcript (FMP), held 2026-11-05
    data/cache/transcripts/AXON-2026Q3.json
    management on the federal Dedrone delays, Skydio, inventory, memory costs, TASER, Body 5, Axon 911 and the license plate reader dispute
    Together, they represent about $130 million of revenue and $200 million of bookings that we expected in the second half of this year.
    backsC06C14C32C33C34C35C41
  7. S07primarycompany filing2026-04-16
    share ownership, the CEO Performance Award and Employee XSP hurdles, and what vested in 2025
    backsC29C30C48
  8. S08primarygovernment data2023-11-01
    the share of local police departments and officers using body-worn cameras in 2016 and 2020, conducted energy device authorisation and drone cameras
    In 2020, 62% of local police departments used body-worn cameras, a 43% increase from 2016
    backsC22C23
  9. S09primarygovernment data2022-10-01
    the number of state and local law enforcement agencies and sworn officers
    agencies employed 1,214,000 persons on a full-time basis, including 788,000 (65%) sworn and 427,000 (35%) civilian personnel.
    backsC24
  10. S10primaryregulator2020-04-23
    the regulator's description of Axon's position in body cameras and evidence systems for large police departments, and of its prices after the VieVu purchase
    The merger eliminated direct and substantial price and innovation competition between dominant supplier Axon and its closest competitor, VieVu, to serve large metropolitan police departments.
    backsC21
  11. S11primarycompany release2023-10-09
    that the FTC case ended in dismissal in October 2023 without a ruling on the merits
    The Federal Trade Commission (FTC) has dismissed its administrative enforcement action against Axon Enterprise Inc.
    read, but no claim rests on it
  12. S12primarycompany filing2026-02-12
    a listed rival's body cameras, evidence software and command centre products, and their weight in its sales
    Video: Cameras (fixed, body-worn, in-vehicle), access control, sensors, infrastructure, video management, video monitoring, software and AI-powered analytics
    backsC25
  13. S13primaryregulator2026-07-06
    that state and local police may run counter-drone operations from 1 July 2026, under federal training and approved systems
    codify the framework for implementing the SAFER SKIES Act, which authorizes State, local, Tribal, and territorial law enforcement or correctional
    backsC37
  14. S14secondaryvendor data2026-11-09
    Research pack frozen beside this thesis, 2026-11-09
    content/AXON/research-pack.json
    the 6 November close, returns and their decomposition, daily closes around results, estimates, the rating split and its history, target drift, valuation history, headcount and FINRA short interest
    backsC16C17C20C40C44C45C51
  15. S15primarycompany filing2026-11-09
    every open-market insider sale in the year and whether it was under a Rule 10b5-1 plan
    backsC31
  16. S16primarycompany filing2026-11-09
    trailing revenue, operating profit, stock pay, tax, debt, cash and the diluted share count
    backsC53
  17. S17secondaryvendor data2026-11-09
    the analysts' average revenue and operating profit for the next three fiscal years, and the close
    backsC52C53
Rendered from content/AXON/thesis.json · thesis reviewed 2026-11-09. This page explains a company; it does not say what to pay, when to buy or how much.